Cognition Therapeutics (CGTX) EPS (Basic) Growth (3y) (2023 - 2026)
Cognition Therapeutics (CGTX) EPS (Basic) Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.60 Bn | 130.75 Bn | 2.84 Bn | 6.85% |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.93 Bn | 3.93 Bn | 11.71% |
| 3 | Argenx Se | 65.06 Bn | 59.88 Bn | 1.37 Bn | 64.84% |
| 4 | Moderna | 56.22 Bn | 51.08 Bn | 52.00 Mn | 18.44% |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 37.21% |
| 6 | Alnylam Pharmaceuticals | 31.65 Bn | 28.34 Bn | 992.69 Mn | 36.73% |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn | -26.87% |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 67.51% |
| 9 | Royalty Pharma | 27.31 Bn | 26.48 Bn | - | -38.31% |
| 10 | Cognition Therapeutics | 88.98 Mn | 88.98 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.74% |
| Mar 31, 2026 | 22.33% |
| Dec 31, 2025 | 28.62% |
| Sep 30, 2025 | 32.83% |
| Jun 30, 2025 | 3.75% |
| Mar 31, 2025 | -9.34% |
| Dec 31, 2024 | 50.78% |
| Sep 30, 2024 | 64.15% |
| Jun 30, 2024 | 46.05% |
| Mar 31, 2024 | -46.47% |
| Dec 31, 2023 | 61.10% |
| Sep 30, 2023 | 54.22% |